A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

NCT07101939 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Muscle Loss

Interventions

DRUG: (S)-pindolol benzoate
DRUG: Semaglutide
DRUG: Placebo to (S)-pindolol benzoate

Sponsor

Actimed Therapeutics Ltd

Collaborators

[object Object]